Corpay
CPAY
402.43
-4.36
-1.07%
Corpay
US · CPAY
#774 by market cap
Listed 1970
402.43
-4.36
-1.07%
Live - 5344 symbols - heartbeat 374s ago
· 2026-10-08 06:43
Pre-market
401.62
-0.20%
After-hours
402.43
0.00%
- Market cap
- 26.42B
- P/E (TTM)i
- 24.48
- P/Bi
- 7.46
- EPSi
- 15.03
- Div yieldi
- 0.00%
- 52W posi
- 86%
Reader sentiment
Are you bullish or bearish on CPAY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.66, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +13.93% YoY
Margins
- Gross margin
- 78.60%
- Operating margin
- 43.10%
- Net margin
- 23.62%
Key ratios & quality
- Enterprise valuei
- 34.02B
- PEG ratioi
- 6.31
- Altman Z-Scorei
- 1.66
PEG uses trailing P/E against the 3-year net income growth rate (3.88%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.43B | 2.65B | 2.39B | 2.83B | 3.43B | 3.76B | 3.97B | 4.53B |
| Gross profit | 1.95B | 2.12B | 1.79B | 2.27B | 2.66B | 2.94B | 3.11B | 3.56B |
| Selling & admin expenses | 571.77M | 612.02M | 567.41M | 747.95M | 893.22M | 943.58M | 997.78M | 1.21B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.09B | 1.23B | 972.27M | 1.24B | 1.45B | 1.66B | 1.76B | 1.95B |
| Pretax profit | 1.10B | 1.08B | 882.53M | 1.11B | 1.28B | 1.33B | 1.39B | 1.54B |
| Tax | 283.64M | 182.75M | 178.31M | 269.31M | 321.33M | 343.12M | 381.38M | 469.73M |
| Net profit | 811.48M | 895.07M | 704.22M | 839.50M | 954.33M | 981.89M | 1.00B | 1.07B |
| Basic EPS | 9 | 10 | 8 | 10 | 13 | 13 | 14 | 15 |
| Diluted EPS | 8.81 | 9.94 | 8.12 | 9.99 | 12.42 | 13.20 | 13.97 | 15.03 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.01B | 1.10B | 1.17B | 1.25B | 1.26B | 1.34B |
| Gross profit | 783.82M | 863.51M | 923.72M | 988.17M | 988.93M | 1.06B |
| Selling & admin expenses | 264.52M | 292.77M | 296.24M | 358.49M | 352.01M | 374.28M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 427.12M | 479.39M | 523.12M | 522.21M | 514.74M | 471.18M |
| Pretax profit | 327.51M | 393.09M | 421.70M | 399.38M | 505.02M | 344.72M |
| Tax | 83.64M | 109.01M | 143.32M | 133.76M | 151.30M | 92.93M |
| Net profit | 243.88M | 284.08M | 278.38M | 265.62M | 353.71M | 251.79M |
| Basic EPS | 3 | 4 | 4 | 4 | 5 | 4 |
| Diluted EPS | 3.40 | 3.98 | 3.91 | 3.75 | 5.07 | 3.70 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.88B | 4.62B | 3.96B | 5.49B | 6.11B | 7.08B | 8.68B | 13.96B |
| Cash & ST investments | 1.03B | 1.27B | 934.90M | 1.52B | 1.44B | 1.39B | 1.55B | 2.41B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 11.20B | 12.25B | 11.19B | 13.40B | 14.09B | 15.48B | 17.96B | 26.41B |
| Total current liabilities | 4.50B | 4.46B | 3.97B | 5.29B | 6.04B | 6.83B | 8.71B | 14.30B |
| Short-term debt | 2.07B | 1.75B | 1.21B | 1.52B | 2.31B | 2.13B | 2.77B | 3.35B |
| Long-term debt | 2.75B | 3.29B | 3.10B | 4.46B | 4.72B | 4.60B | 5.23B | 6.66B |
| Total liabilities | 7,862,297,000.00 | 8,536,925,000.00 | 7,839,168,000.00 | 10,538,073,000.00 | 11,547,767,000.00 | 12,193,893,000.00 | 14,811,042,000.00 | 22,179,458,000.00 |
| Total equity | 3.34B | 3.71B | 3.36B | 2.87B | 2.54B | 3.28B | 3.15B | 4.23B |
| Retained earnings | 3.82B | 4.71B | 5.42B | 6.26B | 7.21B | 8.19B | 9.20B | 10.26B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 9.08B | 10.76B | 10.11B | 13.96B | 14.64B | 16.48B |
| Cash & ST investments | 1.55B | 2.19B | 2.01B | 2.41B | 2.54B | 3.16B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 18.55B | 20.44B | 19.74B | 26.41B | 26.66B | 28.22B |
| Total current liabilities | 8.24B | 9.64B | 8.91B | 14.30B | 14.99B | 16.96B |
| Short-term debt | 2.25B | 2.25B | 2.30B | 3.35B | 3.75B | 4.53B |
| Long-term debt | 5.92B | 5.87B | 5.82B | 6.66B | 6.61B | 6.10B |
| Total liabilities | 15,053,698,000.00 | 16,468,047,000.00 | 15,625,705,000.00 | 22,179,458,000.00 | 22,801,288,000.00 | 24,322,215,000.00 |
| Total equity | 3.49B | 3.97B | 4.12B | 4.23B | 3.86B | 3.90B |
| Retained earnings | 9.44B | 9.72B | 10.00B | 10.26B | 10.61B | 10.86B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 903.38M | 1.16B | 1.47B | 1.20B | 754.80M | 2.10B | 1.94B | 1.50B |
| Depreciation & amortization | 274.61M | 274.21M | 254.80M | 284.20M | 322.28M | 336.60M | 351.09M | 393.30M |
| Free cash flow | 822.00M | 1.09B | 1.39B | 1.09B | 603.37M | 1.95B | 1.77B | 1.30B |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -903.02M | -525.98M | -713.11M | -1.31B | -1.36B | -573.12M | -859.77M | -715.05M |
| Ending cash balance | 1.36B | 1.68B | 1.48B | 2.25B | 2.29B | 3.14B | 4.46B | 8.99B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -74.15M | 1.14B | -378.93M | 812.74M | -56.62M | 1.47B |
| Depreciation & amortization | 92.19M | 91.35M | 93.16M | 116.60M | 114.83M | 118.30M |
| Free cash flow | -118.92M | 1.09B | -429.84M | 760.30M | -107.71M | 1.42B |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -26.64M | -8.28M | -184.65M | -495.48M | -774.25M | -251.85M |
| Ending cash balance | 4.38B | 5.53B | 4.91B | 8.99B | 8.82B | 10.17B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 23.13 | 25.39 | 19.93 | 26.98 | 35.29 | 33.72 | 31.34 | 30.54 |
| ROA %i | 7.21 | 7.63 | 6.01 | 6.83 | 6.94 | 6.64 | 6.00 | 4.82 |
| ROIC %i | 11.18 | 12.06 | 9.83 | 11.20 | 11.70 | 12.67 | 12.13 | 10.80 |
| 5-year avg ROE %i | 18.54 | 19.80 | 21.13 | 23.47 | 26.14 | 28.26 | 29.45 | 31.58 |
| EBIT margin %i | 50.69 | 46.35 | 42.38 | 43.14 | 42.03 | 44.54 | 44.49 | 42.96 |
| FCF / sales %i | 33.78 | 41.03 | 58.36 | 38.31 | 17.61 | 51.82 | 44.42 | 28.69 |
| Current ratioi | 0.86 | 1.03 | 1.00 | 1.04 | 1.01 | 1.04 | 1.00 | 0.98 |
| Quick ratioi | 0.55 | 0.64 | 0.58 | 0.63 | 0.58 | 0.52 | 0.42 | 0.32 |
| Debt / assetsi | 43.02 | 41.12 | 38.44 | 44.59 | 49.95 | 43.44 | 44.53 | 37.87 |
| LT debt / equityi | 82.28 | 88.64 | 92.32 | 155.59 | 185.83 | 140.03 | 167.38 | 171.38 |
| Interest coveragei | 8.91 | 8.18 | 7.80 | 10.75 | 8.75 | 4.80 | 4.62 | 4.82 |
| Revenue CAGR (3Y) %i | 12.64 | 13.09 | 2.02 | 5.21 | 8.97 | 16.30 | 11.94 | 9.73 |
| Net income CAGR (3Y) %i | 30.82 | 25.54 | -1.65 | 1.14 | 2.16 | 11.72 | 6.14 | 3.88 |
| FCF CAGR (3Y) %i | 4.87 | 18.74 | 31.73 | 9.71 | -17.81 | 11.78 | 17.60 | 29.13 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 30.33 | 31.43 | 29.35 | 30.54 | 33.79 | 30.54 |
| ROA %i | 5.92 | 5.73 | 5.62 | 4.82 | 5.21 | 4.69 |
| ROIC %i | 11.99 | 12.01 | 11.42 | 10.80 | 11.50 | 11.00 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 44.38 | 44.50 | 44.39 | 42.96 | 44.72 | 42.00 |
| FCF / sales %i | 33.06 | 46.23 | 26.50 | 28.69 | 27.39 | 32.63 |
| Current ratioi | 1.10 | 1.12 | 1.13 | 0.98 | 0.98 | 0.97 |
| Quick ratioi | 0.68 | 0.67 | 0.72 | 0.32 | 0.34 | 0.48 |
| Debt / assetsi | 44.06 | 39.72 | 41.14 | 37.87 | 38.86 | 37.64 |
| LT debt / equityi | 171.30 | 149.39 | 142.84 | 171.38 | 188.22 | 172.17 |
| Interest coveragei | 4.63 | 4.76 | 4.97 | 4.82 | 5.09 | 4.82 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Vehicle Payments is the largest reported line at 43.34% of revenue, across 4 reported segments.
- No single line clears half of revenue; Corporate payments is next at 40.99%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Vehicle Payments43.34%
Corporate payments40.99%
Lodging Payments9.20%
Other6.48%
Quote time 2026-10-08 06:43:33 · For reference only, not investment advice and not tailored to your situation.